New research suggests that the NAFLD development is determined by gut bacteria [83], while caspase-1/11 has been found to influence the gut microbiome and consequently affect the progression of NAFLD. This evidence concerns the gene CASP1 and metabolic dysfunction-associated steatotic liver disease.